Agios Pharmaceuticals
AGIO
AGIO
144 hedge funds and large institutions have $1.46B invested in Agios Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 56 increasing their positions, 46 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $1.68B → $1.46B (-$216M)
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
48% less call options, than puts
Call options by funds: $6.15M | Put options by funds: $11.9M
Holders
144
Holding in Top 10
1
Calls
$6.15M
Puts
$11.9M
Top Buyers
| 1 | +$11.2M | |
| 2 | +$9.66M | |
| 3 | +$8.8M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$7.72M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.39M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$10.2M | |
| 3 | -$8.4M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$5.37M |
| 5 |
Man Group
London,
United Kingdom
|
-$4.51M |